Call for Abstract

6thEuro-Global Conference on Infectious Diseases, will be organized around the theme “Preventing Emerging Infectious Diseases: New Strategy for the 21st Century”

Euro Infectious Diseases 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Infectious Diseases 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Viral Infectious Disease occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells. There are many types of viruses that cause a wide variety of viral diseases. The most common type of viral disease is the common cold, which is caused by a viral infection of the upper respiratory tract (nose and throat). Viral diseases are contagious and spread from person to person when a virus enters the body and begins to multiply. Viral diseases result in a wide variety of symptoms that vary in character and severity depending on the type of viral infection and other factors, including the person’s age and overall health.

  • Track 1-1Viral molecular epidemiology
  • Track 1-2Zoonotic viral diseases
  • Track 1-3Influenza
  • Track 1-4Respiratory viruses
  • Track 1-5Human Immunodeficiency virus / Acquired Immunodeficiency Syndrome
  • Track 1-6Marburg virus
  • Track 1-7Rabies
  • Track 1-8Smallpox
  • Track 1-9Hantavirus
  • Track 1-10Rotavirus
  • Track 1-11Viral hepatitis
  • Track 1-12Virology
  • Track 1-13Ecology and Others
  • Track 1-14Pox Disease
  • Track 1-15Polio
  • Track 1-16Measles, Mumps, and Rubella
  • Track 1-17Hemorrhagic Fevers and Acute Viral Infections

Bacteria are living things that have only one cell. Under a microscope, they look like balls, rods, or spirals. They are so small that a line of 1,000 could fit across a pencil eraser. Most bacteria won't hurt you - less than 1 percent of the different types make people sick. Many are helpful. Some bacteria help to digest food, destroy disease-causing cells, and give the body needed vitamins. Bacteria are also used in making healthy foods like yogurt and cheese. But infectious bacteria can make you ill. They reproduce quickly in your body. Many give off chemicals called toxins, which can damage tissue and make you sick. Examples of bacteria that cause infections include Streptococcus, Staphylococcus, and E. coli. Antibiotics are the usual treatment. When you take antibiotics, follow the directions carefully. Each time you take antibiotics, you increase the chances that bacteria in your body will learn to resist them causing antibiotic resistance. Later, you could get or spread an infection that those antibiotics cannot cure.

  • Track 2-1Mycobacterial Infections
  • Track 2-2Zoonotic Bacterial Diseases
  • Track 2-3Tetanus
  • Track 2-4Typhoid fever
  • Track 2-5Cholera
  • Track 2-6Plague
  • Track 2-7Syphilis
  • Track 2-8Gonorrhea
  • Track 2-9Tuberculosis
  • Track 2-10Pneumonia
  • Track 2-11Anthrax
  • Track 2-12Bacteraemia & Endocarditis
  • Track 2-13Respiratory infections
  • Track 2-14Genital infections
  • Track 2-15Urinary Tract Infections
  • Track 2-16Bone & Joint Infections
  • Track 2-17Central nervous system infections
  • Track 2-18Ecology and Others
  • Track 2-19Leprosy

Ebola Virus Disease is caused by virus transmitted through body fluids and through air. It occurs rarely but it is very deadly which results in death and outbreak. Ebola Virus Disease symptoms are very severe which appears in two-three days. Ebola primary symptoms include fever, sore throat, muscular pain and headaches then followed by vomiting, diarrhoea, rash, decreased function of the liver and kidneys then loss of blood internally and externally finally leading to low blood pressure and fluid loss resulting in death.

  • Track 3-1Outbreaks
  • Track 3-2Epidemiology of Ebola
  • Track 3-3Symptoms and pathophysiology
  • Track 3-4Diagnosis
  • Track 3-5Molecular genetics and current research
  • Track 3-6Prevention, control and cure
  • Track 3-7Therapeutic measures and vaccination
  • Track 3-8Health care
  • Track 3-9Public awareness

Fungi are everywhere. There are approximately 1.5 million different species of fungi on Earth, but only about 300 of those are known to make people sick. Fungal diseases are often caused by fungi that are common in the environment. Fungi live outdoors in soil and on plants and trees as well as on many indoor surfaces and on human skin. Most fungi are not dangerous, but some types can be harmful to health. Fungal diseases can affect anyone. Learning about them can help you and your doctor recognize the symptoms of a fungal disease early and may help prevent serious complications. Fungal diseases are often caused by fungi that are common in the environment. Most fungi are not dangerous, but some types can be harmful to health. Mild fungal skin diseases can look like a rash and are very common. Fungal diseases in the lungs are often similar to other illnesses such as the flu or tuberculosis. Some fungal diseases like fungal meningitis and bloodstream infections are less common than skin and lung infections but can be deadly.

  • Track 4-1Blastomycosis collapsed
  • Track 4-2Candidiasis collapsed
  • Track 4-3Coccidioidomycosis (Valley Fever) collapsed
  • Track 4-4C. neoformans infection collapsed
  • Track 4-5Fungal eye infections collapsed
  • Track 4-6Histoplasmosis collapsed
  • Track 4-7Mucormycosis collapsed
  • Track 4-8Pneumocystis pneumonia (PCP) collapsed
  • Track 4-9Ringworm collapsed
  • Track 4-10Sporotrichosis collapsed
  • Track 4-11Other pathogenic fungi
  • Track 4-12Fungal disease epidemiology
  • Track 4-13Antifungal drugs & treatment
  • Track 4-14Antifungal resistance
  • Track 4-15Susceptibility testing
  • Track 4-16Ecology and Others

Bacterial resistance is a growing threat and yet few new antibiotics active against multi-resistant bacteria are being explored. A combination of falling profits, regulatory mechanisms and irrational and injudicious use of antibiotics has led to an alarming situation where some infections have no cure. In this article, we summarize the new developments that have been suggested to incentivize the pharmaceutical industries toward the field of infections. We also briefly mention the new compounds on the horizon and some newly approved compounds that might help us tide over this crisis.

  • Track 5-1Mechanisms of action, preclinical data & pharmacology
  • Track 5-2Pharmacokinetics/pharmacodynamics
  • Track 5-3Clinical trials
  • Track 5-4Pharmacoepidemiology
  • Track 5-5New technologies in the development
  • Track 5-6Prescribing Improved agents
  • Track 5-7Advancement

Global Market Reports of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis

  • Track 6-1Disinfection equipments
  • Track 6-2Filter media
  • Track 6-3Devices and instruments
  • Track 6-4Environmental products
  • Track 6-5Pharmaceuticals
  • Track 6-6Nanomaterials
  • Track 6-7Testing tools
  • Track 6-8Molecular diagnostics
  • Track 6-9Municipal water treatment
  • Track 6-10Drug formulation devices
  • Track 6-11Chemicals and bulk drugs
  • Track 6-12Laboratory testing tools
  • Track 6-13Drug device combinations

parasitic disease is an infectious disease caused or transmitted by a parasite. Many parasites do not cause diseases. Parasitic diseases can affect practically all living organisms, including plants and mammals. The study of parasitic diseases is called parasitology. Some parasites like Toxoplasma gondii and Plasmodium spp. can cause disease directly, but other organisms can cause disease by the toxins that they produce. Although organisms such as bacteria function as parasites, the usage of the term "parasitic disease" is usually more restricted. The three main types of organisms causing these conditions are protozoa (causing protozoan infection), helminths (helminthiasis), and ectoparasites. Protozoa and helminths are usually endoparasites (usually living inside the body of the host), while ectoparasites usually live on the surface of the host. Occasionally the definition of "parasitic disease" is restricted to diseases due to endoparasites.  

  • Track 7-1Advances in treatment methods
  • Track 7-2Diagnosis methods
  • Track 7-3Transmission
  • Track 7-4Problems encountered
  • Track 7-5Causes and prevention
  • Track 7-6New Anti parasitic drugs

When a microorganism is isolated from a patient, the microbiology lab will often perform susceptibility testing. There is often confusion about what these results mean and how it can be used by the clinician to guide the treatment of the patient. The goal of antimicrobial susceptibility testing is to predict the in vivo success or failure of antibiotic therapy. Tests are performed in vitro, and measure the growth response of an isolated organism to a particular drug or drugs. The tests are performed under standardized conditions so that the results are reproducible. The test results should be used to guide antibiotic choice. The results of antimicrobial susceptibility testing should be combined with clinical information and experience when selecting the most appropriate antibiotic for your patient.

  • Track 8-1MRSA, VRE & other Gram-positives
  • Track 8-2Gram-negative
  • Track 8-3Susceptibility testing methods
  • Track 8-4Mechanisms of Resistance.
  • Track 8-5Bacterial infection in vivo
  • Track 8-6Sensitivity Testing Advances

Nosocomial infections are infections are acquired in hospitals and other healthcare facilities. To be classified as a Nosocomial infection, the patient must have been admitted for reasons other than the infection. He or she must also have shown no signs of active or incubating infection. Urinary tract infections are the most common type of nosocomial infection. In the United States, surgical site infections, bloodstream infections, and pneumonia are the other most common types. The location of a nosocomial infection depends on the nature of a patient's hospital procedure. 

  • Track 9-1Detecting emerging threats in healthcare
  • Track 9-2Chances of occurring
  • Track 9-3Infection Control
  • Track 9-4Intravascular catheter-related infections
  • Track 9-5Foreign-body and implant infections
  • Track 9-6Surgical site infections
  • Track 9-7Surveillance & Epidemiology
  • Track 9-8Disinfection

Healthcare-associated infections are a threat to patient safety. Hospitalization for an acute illness, trauma, chronic care, or other health care conditions is a common occurrence. There were 39.2 million hospital discharges in 2005, with an average length of stay of 4.6 days. Hospitalization brings associated risks, including risk of infection. Nosocomial infections, or hospital-associated infections, are estimated to occur in 5 percent of all acute care hospitalizations, or 2 million cases per year. Hospital-associated infections have been identified as one of the most serious patient safety issues in health care. Infections that become clinically evident after 48 hours of hospitalization are considered hospital-associated. Risks factors for hospital-associated infections are generally categorized into three areas: iatrogenic, organizational, or patient-related. Iatrogenic risk factors include invasive procedures (e.g., intubation, indwelling vascular lines, urine catheterization) and antibiotic use and prophylaxis. Organizational risk factors include such things as contaminated air-conditioning systems, contaminated water systems, staffing (e.g., nurse-to-patient ratio), and physical layout of the facility (e.g., open beds close together). Examples of patient-related risk factors include severity of illness, immunosuppression, and length of stay.

  • Track 10-1Detecting emerging threats in healthcare
  • Track 10-2Tracking and preventing healthcare-associated infections
  • Track 10-3Innovative strategies to control and prevent healthcare-associated infections
  • Track 10-4Healthcare worker safety/infection control
  • Track 10-5Blood, organ, and other tissue safety

The Public Health Practice concentration is geared toward students who are able to enroll in courses that utilize a combination of on-line, video conference, and in person teaching modalities.  Students selecting the public health practice program should possess an academic background in a public health related field and/or experience working or volunteering within at least one public health program. Work includes subject matter in the core areas of public health: Epidemiology, Biostatistics, Environmental and occupational health, Public health policy and management, Socio-cultural and behavioral aspects of public health.

  • Track 11-1Improvement
  • Track 11-2Improving preparedness for infectious disease emergencies
  • Track 11-3Role of health communication
  • Track 11-4Outbreak investigation: lab and epi response
  • Track 11-5Infectious diseases and policy implications
  • Track 11-6Strengthening public health systems

The increase in life expectancy during the 20th century is largely due to improvements in child survival; this increase is associated with reductions in infectious disease mortality, due largely to immunization. However, infectious diseases remain a major cause of illness, disability, and death.Immunization recommendations in the United States currently target 17 vaccine-preventable diseases across the lifespan. Healthy People 2020 goals for immunization and infectious diseases are rooted in evidence-based clinical and community activities and services for the prevention and treatment of infectious diseases. Objectives new to Healthy People 2020 focus on technological advancements and ensuring that States, local public health departments, and nongovernmental organizations are strong partners in the Nation’s attempt to control the spread of infectious diseases. Objectives for 2020 reflect a more mobile society and the fact that diseases do not stop at geopolitical borders. Awareness of disease and completing prevention and treatment courses remain essential components for reducing infectious disease transmission.

  • Track 12-1Advances and Development
  • Track 12-2Vaccine-preventable diseases (VPDs)
  • Track 12-3New Approches in Polio Eradication
  • Track 12-4Surveillance for VPDs

Respiratory disease is a medical term that encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing. Respiratory diseases range from mild and self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, and lung cancer. The study of respiratory disease is known as pulmonology. A doctor who specializes in respiratory disease is known as a pulmonologist, a chest medicine specialist, a respiratory medicine specialist, a respirologist or a thoracic medicine specialist. UBET Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause (aetiology) of the disease. 

  • Track 13-1H1N1
  • Track 13-2Bacterial and Viral Infections
  • Track 13-3Prevention challenges for respiratory diseases in community and healthcare settings
  • Track 13-4Controlling such diseases
  • Track 13-5Others

Clinical infectious diseases are highly harmful pathogens that spread throughout the body. These pathogenic agents consist of parasites, viruses and bacteria and create communicable diseases between humans and animals. Infectious diseases are transmitted in several ways including contact from one person to another, airborne germs and bodily fluids. 

Infectious diseases have a substantial impact on the health of communities around the world. The global HIV and tuberculosis (TB) epidemics, to the threat of resistant bacteria, to the challenge of emerging and newly identified pathogens. All we need a new methods to detect such pathogens, to understand their pathogenesis, and to devise effective interventions for their prevention and control.

Emerging infectious disease that has newly appeared in a population known for some time but is rapidly increasing in geographic range. Emerging infections account for at least 12% of all human pathogens. EIDs are caused by newly identified species that may have evolved from a known infection or spread of new population undergoing ecologic transformation, like drug resistant tuberculosis. 

Laboratory tests may identify organisms directly or indirectly. General types of tests include microscopy, culture, Immunologic tests and identification test by nucleic acid based or Non nucleic acid based.

Human populations presumably have suffered and currently suffering from infectious diseases similar or identical to diseases of other wild primate populations. However, the most important infectious diseases of human populations also include diseases that could have emerged only within the past 11,000 years. These diseases can only be sustained in large dense human populations that did not exist anywhere in the world. 

The research interests on how pathogens are transmitted and controlled including, environmental survival, vector biology, wildlife reservoirs and biofilms in intensive farming units and processing in life forms. Pathogen evolution and understanding the molecular basis of pathogenesis are closely related with bioinformatics and genetics groups. The strong focus on antimicrobial resistance including the antimicrobial resistance and how it influences pathogen fitness and the development of novel control strategies including vaccines and probiotics.

Infectious Diseases and Microbiology has various aspects of infectious diseases and host-pathogen interactions, including the pathogenesis of microbial infections at the cellular and molecular levels as they relate the developing methods for disease prevention. Results of landmark clinical trials have led to significant advances in the fight against infectious diseases.

In many areas of the world, it is increasingly based on wildlife is potentially more profitable than livestock raising, the consequences being that more and more land-owners are deserting livestock production. This sometimes conflicts with the policies of developing countries, which place a premium on agriculture and industrial development, and has led to the criticism that wildlife is held in higher regard than people.

Sexually transmitted infections (STI), also known as sexually transmitted diseases (STD) and venereal diseases (VD), are infections that are commonly spread by sex, especially vaginal intercourse, anal sex and oral sex. Most STIs initially do not show any symptoms. This results in a greater risk of passing the disease on to others. Symptoms of disease may include vaginal discharge, penile discharge, ulcers around the genitals, and pelvic pain. STIs acquired before or during birth may result in poor outcomes for the baby. Some STIs may cause problems with the ability to get pregnant.

  • Track 25-1HIV – Human Immunodeficiency Virus
  • Track 25-2Chlamydia
  • Track 25-3Gonorrhea
  • Track 25-4Genital Herpes
  • Track 25-5Genital Warts
  • Track 25-6Syphilis
  • Track 25-7Hepatitis B

Infectious Diseases of the Female Genital Tract remains as a cornerstone and a major source of comprehensive and practical information on medical issues related to female genital tract infections. Gynecological study includes arrangement of epidemiology, predisposing factors, pathophysiology, clinical manifestations, diagnosis, novel therapies, and prevention diseases.

From  past several years, the development and application of molecular diagnostic techniques had made an revolution in the diagnosis and monitoring of infectious diseases. Molecular diagnostics are used to identify infectious diseases like chlamydia, influenza virus and tuberculosis. Genetic identification can be made for example a loop-mediated isothermal amplification test diagnoses the malaria parasite in the developing countries. But despite these advances in genome analysis, in 2013 infections are still more often identified by other means like proteome, bacteriophage, or chromatographic profile. Molecular diagnostics are  used to understand the specific strain of the pathogen—for example by detecting which drug resistance genes it possesses—and hence which therapies to avoid.

Children are at increased risk of some infectious diseases because they don’t have enough immunity to withstand, they tend to gather in groups, and they may have difficulty with some aspects of hygiene. Pediatric Infectious Diseases is the branch of medicine that deals diagnosis, control and treatment of infections in infants, children, and adolescents.

The genome sequencing approach has proved to be highly effective for gaining an insight on structure of bacteria genomes and the biological evolution of bacteria. In Recent, interest in microbial pathogens and infectious diseases is largely attributed to the emergency of infectious diseases like tuberculosis, emergence of new infectious diseases like AIDS and severe acute respiratory syndrome, the problem of an increasing rate of antibiotic-resistant variants of pathogens, and the fear of bioterrorism. Microarray technology that made an use of the genomic sequencing of human and bacterial pathogens is a major tool for gaining full understanding of the complexity of host-pathogen interactions and mechanisms of pathogenesis.

Drug interaction is that in which another drug affects the activity of a drug when both are administered together. This action can be synergistic when the drug's effect is increased or decreased or a new effect can be produced that neither produces on its own. Innovations in drug development have led to the introduction of many chemical entities in clinical practice over the past years. Drug Interactions in Infectious Diseases is a distillation of relevant drug interactions associated with antimicrobials, infection, and inflammation.

Infectious diseases include any disease or an illness caused by germs, such as bacteria and viruses. Children are often at an increased risk for certain conditions while their immune systems are still developing. Infections are a common part of childhood, but some infections ail children for long periods of time potentially their entire lives or have very serious symptoms that need specialized treatment.

 

Tropical medicine is the branch of medicine that deals with health problems that occur uniquely, are more widespread, or prove more difficult to control in tropical and subtropical regions. Many infections and infestations that are classified as "tropical diseases" used to be endemic in countries located in the tropics. This includes widespread epidemics such as malaria, Ebola and hookworm infections as well as exceedingly rare diseases like lagochilascaris minor.

Intensive care medicine is a branch of medicine concerned with the diagnosis of life-threatening conditions requiring sophisticated organ support and invasive monitoring. Critical illness is a cause and a consequence of serious infections with a diverse spectrum of pathogens at various anatomic sites. The practice of critical care medicine has become more multidisciplinary pursuit  involves a wide range of practitioners who have training in general medicine, specialty areas critical care medicine, pulmonary medicine, cardiology and various degrees of knowledge about infection. Basic and clinical investigation on diagnosis, treatment, and prevention of infection in the complex critical-care patient population.

Arthropod borne diseases are transmitted by the members of invertebrate phylum Arthropoda, which are insects, spiders, and crustaceans. Infectious diseases, such as malaria, dengue fever, yellow fever, and plague, cause a significant impact on global infectious disease. Nearly half of the world’s population is infected with at least one type of vector-borne pathogen. 

Infectious diseases are the leading cause of illness and death throughout the world.  The enormous diversity of microbes combined with their ability to evolve and to adapt the changing populations, environments, practices, and technologies that creates ongoing threats to health and continually challenges our efforts to prevent and control infectious diseases.  

Feline Infectious Diseases is a viral infection which may cause severe illness in unprotected cats. Signs include diarrhea/vomiting and the cat will show marked depression. Infection during pregnancy can lead to brain damage in the kittens. The virus is resistant and can remain in the environment for up to 12 months. Effective vaccination is given at 9th and 12th week as an annual booster. Catteries insist on Feline Infectious Enteritis vaccination before boarding.

Tropical regions of the world were more seriously affected by infectious diseases in comparison to the temperate world. Principal reasons why infectious diseases can thrive in such regions of both environmental and biological factors that support high levels of biodiversity of pathogens, vectors and hosts, but also in social factors that undermine efforts to control these diseases. Such infectious diseases are known simply as tropical diseases disproportionately more prevalent than other non-infectious diseases. The most important part of the research is figuring out the relationship between humans and microorganism, and a vector that can move the pathogen between humans. Tropical diseases can be kept under the control by distributing medications, improving living conditions and building waste sanitation facilities.

According to the Centres for Disease Control and Prevention (CDC), more than two million Americans develop antibiotic resistant infections each year, resulting in 23,000 deaths. As of March 2015, over 24,700 individuals had infected with the Ebola virus globally, and nearly half of this population had died. 10,000 Americans were diagnosed with Tuberculosis (TB) in 2013, An estimated 4% of the population was infected with asymptomatic TB. Even though malaria is preventable and treatable, it still caused approximately 627,000 deaths globally in 2012.

The Research programme on infectious diseases comprises Poverty Related Diseases (PRD), Which including the main scourges i.e., HIV/AIDS, malaria and tuberculosis, Anti-microbial Drug Resistance (AMDR), Emerging Epidemics (EE) and Neglected Infectious Diseases (NID). The strategic objective of this area is to confront HIV/AIDS, malaria and tuberculosis in Europe and the rest of the world is at broad fronts and in a multidisciplinary approach through the development of effective preventive and controlling strategies. Clinical evaluation of vaccine and drugs are facilitated through the European and the Developing Countries Clinical Trials Partnership (EDCTP), which is a pioneer programme of the European Union specifically tailored to meet the needs of developing countries, focused on phase II and III clinical trials of vaccines and drugs against HIV, malaria and tuberculosis and of HIV microbicides. 

Infectious diseases are still a major health and economic burden in UK. Human infectious diseases in England including costs to the health service, labour market and the individual are estimated £30 billion per year. The number of reported diagnoses of gonorrhoea increased 25% from 2010 to 2013. in 2012 there were 8,741 cases of TB, around estimated 25% of the population is affected by gastrointestinal infection each year. In 2011 apporximately 21% of all days of work were lost because of coughs, cold and flu.

Since 10 years severe acute respiratory syndrome (SARS) emerged, and East and Southeast Asia retain a reputation as a major area of emerging infectious diseases. The region is certainly a highly effected areas for the socioeconomic and environmental change, and although some changes may reduce the probability of emerging infectious diseases, the effect of any individual emergence event may increase the greater concentration and connectivity of livestock, persons, and products. The region is now better able to detect and respond to emerging infectious diseases. But the tools and methods to produce sufficient refined assessments of the risks of disease emergence are still lacking. 

As a region, Africa is characterized by the highly infected area and, overall, the weakest public health infrastructure among all regions in the world. Frequently, vertically oriented disease surveillance programs at the national level and in Africa often result in too much paperwork, too many different instructions, terminologies, administrators, and conflicting priorities and streamlined communications, strengthened public health surveillance, the use of standard case definitions, The major criteria for minimum data requirements, and emphasis on feedback through the integrated forms, as well as research and training opportunities, are among the important tools available to improve the situation. Yet, efforts to establish fully more effective public health information may take a period of years to decades. The main aim of Africa is to identify a group of priority diseases categorized as epidemic- prone diseases, diseases targeted for eradication or elimination, and other diseases of public health importance.